Characterization of T helper (Th)1- and Th2-type immune responses caused by baculovirus-expressed protein derived from the S2 domain of feline infectious peritonitis virus, and exploration of the Th1 and Th2 epitopes in a mouse model

Microbiology and Immunology

Volumn 54, Issue 12, 2010, Pages 726-733

  Satoh, Ryoichi ^a   Kobayashi, Hiroshige ^a   Takano, Tomomi ^a   Motokawa, Kenji ^b   Kusuhara, Hajime ^b   Hohdatsu, Tsutomu ^a  

^a KITASATO UNIVERSITY   (Japan)

^b KITASATO INSTITUTE   (Japan)

Author keywords

Coronavirus; Feline infectious peritonitis virus; Th1 type immune response

Indexed keywords

EPITOPE; GAMMA INTERFERON; HEPTAD REPEAT FUSION PROTEIN; HYBRID PROTEIN; INTERLEUKIN 2; INTERLEUKIN 4; UNCLASSIFIED DRUG; VIRUS INTERHELICAL PROTEIN; VIRUS PRECOIL PROTEIN; VIRUS PROTEIN; VIRUS SPIKE PROTEIN;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BACULOVIRUS EXPRESSION SYSTEM; CARBOXY TERMINAL SEQUENCE; CELL STIMULATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CORONAVIRUS; FEMALE; IMMUNIZATION; IMMUNOGENICITY; MOUSE; NONHUMAN; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; SPLEEN CELL; TH1 CELL; TH2 CELL; VIRUS STRAIN;

AMINO ACID SEQUENCE; ANIMALS; BACULOVIRIDAE; CORONAVIRUS, FELINE; EPITOPES, T-LYMPHOCYTE; FEMALE; IMMUNIZATION; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; RECOMBINANT PROTEINS; TH1 CELLS; TH2 CELLS;

CORONAVIRUS; FELIDAE; FELINE INFECTIOUS PERITONITIS VIRUS;

EID: 78649498969     PISSN: 03855600     EISSN: 13480421     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2010.00275.x     Document Type: Article

References (27)

1. Barlough J.E., Stoddart C.A., Sorresso G.P., Jacobson R.H., Scott F.W. (1984) Experimental inoculation of cats with canine coronavirus and subsequent challenge with feline infectious peritonitis virus. Lab Anim Sci 34: 592-7.
2. Pedersen N.C. (2009) A review of feline infectious peritonitis virus infection: 1963-2008. J Feline Med Surg 11: 225-58.
3. Pedersen N.C., Black J.W. (1983) Attempted immunization of cats against feline infectious peritonitis, using avirulent live virus or sublethal amounts of virulent virus. Am J Vet Res 44: 229-34.
4. Pedersen N.C., Boyle J.F., Floyd K., Fudge A., Barker J. (1981) An enteric coronavirus infection of cats and its relationship to feline infectious peritonitis. Am J Vet Res 42: 368-77.
5. Pedersen N.C., Evermann J.F., Mckeirnan A.J., Ott R.L. (1984) Pathogenicity studies of feline coronavirus isolates 79-1146 and 79-1683. Am J Vet Res 45: 2580-5.
6. Stoddart C.A., Barlough J.E., Baldwin C.A., Scott F.W. (1988) Attempted immunisation of cats against feline infectious peritonitis using canine coronavirus. Res Vet Sci 45: 383-8.
7. Woods R.D., Pedersen N.C. (1979) Cross-protection studies between feline infectious peritonitis and porcine transmissible gastroenteritis viruses. Vet Microbiol 4: 11-6.
8. Pedersen N.C., Boyle J.F. (1980) Immunologic phenomena in the effusive form of feline infectious peritonitis. Am J Vet Res 41: 868-76.
9. Weiss R.C., Scott F.W. (1981) Antibody-mediated enhancement of disease in feline infectious peritonitis: comparisons with dengue hemorrhagic fever. Comp Immunol Microbiol Infect Dis 4: 175-89.
10. Bosch B.J., Van Der Zee R., De Haan C.A., Rottire P.J. (2003) The coronavirus spike protein is a class I virus fusion protein: structural and functional characterization of the fusion core complex. J Virol 77: 8801-11.
11. Olsen C.W. (1993) A review of feline infectious peritonitis virus: molecular biology, immunopathogenesis, clinical aspects, and vaccination. Vet Microbiol 36: 1-37.
12. Dimitrov D.S. (2004) Virus entry: molecular mechanisms and biomedical applications. Nat Rev Microbiol 2: 109-22.
13. Corapi W.V., Darteil R.J., Audonnet J.C., Chappuis G.E. (1995) Localization of antigenic sites of the S glycoprotein of feline infectious peritonitis virus involved in neutralization and antibody-dependent enhancement. J Virol 69: 2858-62.
14. Corapi W.V., Olsen C.W., Scott F.W. (1992) Monoclonal antibody analysis of neutralization and antibody-dependent enhancement of feline infectious peritonitis virus. J Virol 66: 6695-705.
15. Hohdatsu T., Nakamura M., Ishizuka Y., Yamada H., Koyama H. (1991) A study of the mechanism of antibody-dependent enhancement of feline infectious peritonitis virus infection in feline macrophages by monoclonal antibodies. Arch Virol 120: 207-17.
16. Hohdatsu T., Yamada H., Ishizuka Y., Koyama H. (1993) Enhancement and neutralization of feline infectious peritonitis virus infection in feline macrophages by neutralizing monoclonal antibodies recognizing different epitopes. Microbiol Immunol 37: 499-504.
17. Hohdatsu T., Yamada M., Tominaga R., Makino K., Kida K., Koyama H. (1998) Antibody-dependent enhancement of feline infectious peritonitis virus infection in feline alveolar macrophages and human monocyte cell line U937 by serum of cats experimentally or naturally infected with feline coronavirus. J Vet Med Sci 60: 49-55.
18. Kida K., Hohdatsu T., Fujii K., Koyama H. (1999) Selection of antigenic variants of the S glycoprotein of feline infectious peritonitis virus and analysis of antigenic sites involved in neutralization. J Vet Med Sci 61: 935-8.
19. Olsen C.W., Corapi W.V., Ngichabe C.K., Baines J.D., Scott F.W. (1992) Monoclonal antibodies to the spike protein of feline infectious peritonitis virus mediate antibody-dependent enhancement of infection of feline macrophages. J Virol 66: 956-65.
20. Bai B., Lu X., Meng J., Hu Q., Mao P., Lu B., Chen Z., Yuan Z., Wang H. (2008) Vaccination of mice with recombinant baculovirus expressing spike or nucleocapsid protein of SARS-like coronavirus generates humoral and cellular immune responses. Mol Immunol 45: 868-75.
21. + T cells to severe acute respiratory syndrome (SARS) coronavirus in recovered SARS patients and healthy individuals. J Immunol 175: 591-8.
22. Tsao Y.P., Lin J.Y., Jan J.T., Leng C.H., Chu C.C., Yang Y.C., Chen S.L. (2006) HLA-A*0201 T-cell epitopes in severe acute respiratory syndrome (SARS) coronavirus nucleocapsid and spike proteins. Biochem Biophys Res Commun 344: 63-71.
23. + T-cell epitope SSp-1 of SARS-CoV spike protein. Blood 104: 200-6.
24. Wang Y.D., Sin W.Y., Xu G.B., Yang H.H., Wong T.Y., Pang X.W., He X.Y., Zhang H.G., Ng J.N., Cheng C.S., Ju J., Meng L., Yang R.F., Lai S.T., Guo Z.H., Xie Y., Chen W.F. (2004) T-cell epitopes in severe acute respiratory syndrome (SARS) coronavirus spike protein elicit a specific T-cell immune response in patients who recover from SARS. J Virol 78: 5612-8.
25. Zhou M., Xu D., Li X., Li H., Shan M., Tang J., Wang M., Wang F.S., Zhu X., Tao H., He W., Tien P., Gao G.F. (2006) Screening and identification of severe acute respiratory syndrome-associated coronavirus-specific CTL epitopes. J Immunol 177: 2138-45.
26. Antón I.M., Suñé C., Meloen R.H., Borrás-Cuesta F., Enjuanes L. (1995) A transmissible gastroenteritis coronavirus nucleoprotein epitope elicits T helper cells that collaborate in the in vitro antibody synthesis to the three major structural viral proteins. Virology 212: 746-51.
27. Zhao J., Huang Q., Wang W., Zhang Y., Lv P., Gao X.M. (2007) Identification and characterization of dominant helper T-cell epitopes in the nucleocapsid protein of severe acute respiratory syndrome coronavirus. J Virol 81: 6079-88.